DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00033943 (ClinicalTrials.gov)	January 2001	16/4/2002	Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis	A Multi-Center, Placebo-Controlled Evaluation of the Safety and Efficacy of Two Dosage Levels of OP2000 (75 Mg and 125 Mg) Administered Once Daily by Subcutaneous Injection for the Treatment of Active Ulcerative Colitis	Ulcerative Colitis	Drug: deligoparin	Incara Pharmaceuticals	NULL	Completed	18 Years	60 Years	Both	270	Phase 2;Phase 3	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00033943
(ClinicalTrials.gov)

January 2001

16/4/2002

Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis

A Multi-Center, Placebo-Controlled Evaluation of the Safety and Efficacy of Two Dosage Levels of OP2000 (75 Mg and 125 Mg) Administered Once Daily by Subcutaneous Injection for the Treatment of Active Ulcerative Colitis

Ulcerative Colitis

Drug: deligoparin

Incara Pharmaceuticals

NULL

Completed

18 Years

60 Years

Both

270

Phase 2;Phase 3

United States